| SESSION 10: NEW DEVELOPMENTS IN CONTRACEPTION,
SEXUAL AND REPRODUCTIVE HEALTH |
 |
||
| nr. | title | 1st
author |
abstract |
| P181 | Enhancement of the specific advantages of the drospirenone-containing pill by long-cycle contraception | A.O. Mueck (Germany) | abstract |
| P182 | Is Evra, a transdermal, once-weekly, combined contraceptive patch cost-effective compared to
combined oral contraceptives? |
F.A. Sonnenberg (USA) | abstract |
| P183 | Effect of oral contraceptives on endogenous estradiol metabolism | A.O. Mueck (Germany) | abstract |
| P184 | New FDA approved latex-free contraceptive device: FemCap | A. Shihata (USA) | abstract |
| P185 | New combined oral contraceptive containing drospirenone and changes in body weight during six
usage cycles |
D. Driák (Czech Republic) | abstract |
| P186 | First pill teach | K. Guthrie (UK) | abstract |
| P187 | An assessment of the use of Implanon® in Luton | A. Agrawal (UK) | abstract |
| P188 | Can there be a genetic background of the primary idiopathic infertility? The leukemia-inhibitory factor
gene mutations in the population of infertile women |
Z. Rokyta (Czech Republic) | abstract |
| P189 | Using menstrual data to time the administration of mifepristone as once-a-month contraceptive pill | N. Narvekar (UK) | abstract |
| P190 | Determinants of use of the monthly contraceptive ring – a study of the Basque Society of
Contraception |
R. Lertxundi (Spain) | abstract |
| P191 | NuvaRing does not interact with oral antibiotics | P. Dogterom (The Netherlands) | abstract |
| P192 | NuvaRing does not affect bone mineral density in pre-menopausal women | R. Massai (Chile) | abstract |
| P193 | Holistic sexual health care in recipients of high dose chemotherapy or chemo-radiotherapy and bone
marrow transplantation for haematological malignancy presenting with sexual dysfunction |
R. Chatterjee (UK) | abstract |
| P194 | Office hysteroscopic sterilization using the Essure micro-insert device | M. Martinho (Portugal) | abstract |
| P195 | Low-dose mifepristone inhibits endometrial proliferation and up-regulates androgen and glucocorticoid
receptor |
N. Narvekar (UK) | abstract |
| P196 | Does use of the combined oral contraceptive pills cause changes in nasal physiology in young women? | C.M. Philpott (UK) | abstract |
| P197 | Uterine manipulation with plastic suction curette at combined abortion and sterilization | A.K. Banerjee (UK) | abstract |
| P198 | Prevention of errors when using oral contraceptives | M. Havlín (Czech Republic) | abstract |
| P199 | Cycle control with NuvaRing is superior to a 30 mg ethinylestradiol oral contraceptive | K. Oddsson (Iceland) | abstract |
|
|||